Search

Displaying results 3311 - 3320 of 4588 in total
  1. Drug

    Eritoran

    go.drugbank.com/drugs/DB04933
    Investigational

    It is being developed by Eisai Research Institute of Boston for the treatment of severe sepsis.

  2. Drug

    NRP369

    go.drugbank.com/drugs/DB06384
    Experimental

    NRP369 was developed by New River Pharmaceuticals as a backup therapeutic to [NRP290].

  3. Drug

    AT-7519

    go.drugbank.com/drugs/DB08142
    Investigational

    It is developed by Astex for the treatment of solid tumours and haematological malignancies.

  4. Drug

    Dipropyl-4-hydroxytryptamine

    go.drugbank.com/drugs/DB13990
    Experimental

    Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. This agent and its properties haven't been fully elucidated.

  5. Drug

    (5Z,7E,9)-decatrien-2-one

    go.drugbank.com/drugs/DB15619
    Investigational

    An compound produced by _Fomitopsis betulina_, an edible fungus commonly called the birch polypore. Similar to [(5E,7E,9)-decatrien-2-one], it has a strong pineapple aroma.[A191116]

  6. Drug

    Beractant

    go.drugbank.com/drugs/DB06761
    Approved

    Beractant is a pulmonary surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in premature infants. Considered a natural source of surfactant as it is made from bovine lung extract, beractant contains a mixture of pho...

  7. Drug

    Rupatadine

    go.drugbank.com/drugs/DB11614
    ApprovedInvestigational

    Rupatadine is a dual histamine H1 receptor and platelet activating factor receptor antagonist that is used for symptomatic relief in seasonal and perennial rhinitis as well as chronic spontaneous urticaria. It was approved for marketing ...

  8. Drug

    Dexamethasone isonicotinate

    go.drugbank.com/drugs/DB11487
    ExperimentalVet approved

    Dexamethasone isonicotinate is an anti-inflammatory, anti-allergic glucocorticoid that can be administered orally, by inhalation, topically, and parenterally.

  9. Drug

    Patritumab

    go.drugbank.com/drugs/DB12090
    Investigational

    Patritumab has been used in trials studying the treatment of LUNG CANCER, Solid Tumors, Neoplasms by Site, Head and Neck Neoplasms, and Non-small Cell Lung Cancer, among others.

  10. Drug

    AT9283

    go.drugbank.com/drugs/DB05169
    Investigational

    AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer.